Transurethral resection of the prostate

doi:10.1017/CBO9780511920660.143

Chapter 139 - Transurethral resection of the prostate

from Section 26 - Urologic Surgery

Published online by Cambridge University Press: 05 September 2013

Muta M. Issa and

Edited by

Thomas F. Dodson and

Michael F. Lubin: Affiliation:
Emory University, Atlanta
Thomas F. Dodson: Affiliation:
Emory University, Atlanta
Neil H. Winawer: Affiliation:
Emory University, Atlanta

Book contents

Get access

Summary

Transurethral resection of the prostate (TURP), developed in the 1920s, remains the gold standard surgical treatment for benign prostatic hyperplasia (BPH) throughout the world. Over the years, the procedure has undergone significant modifications that improved its efficacy and safety. The most significant recent improvement is bipolar TURP. Conventional monopolar TURP employs hypo-osmolar fluids for irrigation during the procedure. As a result, patients are at risk of developing perioperative dilutional hyponatremia and TUR syndrome, which is a severe form of serum electrolyte and osmolar derangement. Since the new bipolar TURP system utilizes normal saline for irrigation, these risks and complications are completely eliminated. Bipolar TURP thus allows for safer resection.

Indications for transurethral resection of the prostate

Transurethral resection of the prostate is the treatment of choice in patients with moderate to severe BPH symptoms and significant compromise to their quality of life who:

Are unable to tolerate or do not respond to other forms of management (e.g., watchful waiting, medical therapy and/or minimally invasive thermal therapy).
Are experiencing urinary retention thought to be secondary to BPH.
Have recurrent urinary infection secondary to BPH.
Have bladder stones secondary to BPH.
Have renal failure secondary to BPH.
Have recurrent bleeding (gross hematuria) secondary to BPH.

Type: Chapter
Information: Medical Management of the Surgical Patient
A Textbook of Perioperative Medicine
, pp. 790 - 793

DOI: https://doi.org/10.1017/CBO9780511920660.143 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Issa, MM, Marshall, FF.Contemporary Diagnosis and Management of Diseases of the Prostate. 3rd edn. Newtown, PA: Handbooks in Healthcare; 2005, pp. 103–12.Google Scholar

Issa, MM.Technological advances in transurethral resection of the prostate – bipolar versus monopolar TURP. J Endourol 2008; 8: 1587–95.CrossRef Google Scholar

Issa, MM, Young, MR, Bullock, AR, Bouet, R, Petros, JA.Dilutional hyponatremia in TURP syndrome – a historical event in the 21st century. Urology 2004; 64: 298–301.CrossRef Google Scholar PubMed

McVary, KT, Roehrborn, CG, Avins, AL et al. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia. Linthicum, MD: American Urological Association, 2010. .Google Scholar

Wasson, JH, Reda, DJ, Bruskewitz, RC et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperation Study Group of Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 75–9.CrossRef Google Scholar